Photos: Øystein Horgmo, UiO and NIPH
Oslo Diabetes Research Centre unites diabetes research within Oslo University Hospital, the University of Oslo and the Norwegian Institute of Public Health.
The Swedish Child Diabetes Foundation (Barndiabetesfonden), dedicated to supporting research aimed at preventing, curing, or alleviating diabetes in children and adolescents, has announced the opening of its 2025 research grant applications.
DD2 - Danish Centre for Strategic Research in type 2 diabetes has announced an upcoming research seminar. This seminar will guide attendees on how to leverage the unique DD2 cohort for their research and secure funding for their projects through the Novo Nordisk Foundation.
Noen mennesker får ikke bedret insulinfølsomhet av trening, til tross for økt VO2max og muskelstyrke. Serumproteomikk og maskinlæring kan brukes til å forutsi hvem dette gjelder, noe som på sikt kan gi bedre persontilpasset behandling.
En nylig publisert studie utforsker de molekylære effektene av en 12-ukers intervensjon med en kombinasjon av styrke- og utholdenhetstrening.
A new paper authored by Professor Knut Dahl-Jørgensen explores the potential link between viral infections and the onset of type 1 diabetes.
The Norwegian Childhood Diabetes Registry (NCDR) has recently received significant recognition in the latest issue of Diabetes Care.
We are proud to announce that a new study from the Sindre Lee-Ødegaard and the MyoGlu group has been recognized as one of the top ten most cited articles in Acta Physiologica for the period 2022–2023.
Professor Emeritus Knut Dahl-Jørgensen was honored with the prestigious Knud Lundbæk award from the Scandinavian Society for the Study of Diabetes (SSSD) during its Annual Meeting in Helsinki on 24 May.
Sørasiater i Norge har høy risiko for type 2 diabetes, men mekanismene bak dette er ukjent. Vi sammenlignet derfor 179 sørasiatiske og 108 nordiske kvinner etter svangerskapsdiabetes.
Success in achieving International Society for Pediatric and Adolescent Diabetes’ glycemic targets varies considerably among countries. This paper seeks to evaluate how HbA1c levels and the use of diabetes technology changed in Norway from 2013 to 2022 and how different measures influence glycemic control.